文献速递肝病

类风湿关节炎患者非酒精性脂肪性肝病患病率的系统评价与Meta分析

Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-03-05

系统检索截至2022年8月31日的观察性研究,纳入9项研究共2178例类风湿关节炎(RA)患者。RA患者非酒精性脂肪性肝病(NAFLD)合并患病率为35.3%(95%CI 19.9-50.6)。男性RA患者NAFLD患病率显著高于女性,体重指数每增加1单位与NAFLD风险增加24%直接相关。

要点

  • RA患者NAFLD合并患病率为35.3%,约每3例RA患者中1例合并NAFLD。
  • 男性RA患者NAFLD患病率35.2%显著高于女性22.2%,交互作用P=.048。
  • 体重指数每增加1单位,RA患者NAFLD风险增加24%(调整OR 1.24)。

核心结论

  • 基于本Meta分析,约1/3的RA患者合并NAFLD,该患病率与一般人群总体患病率似乎相当。
  • 临床医生应主动对RA患者进行NAFLD筛查。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase、Web of Science、Scopus和ProQuest,纳入从建库至2022年8月31日发表的观察性研究。
  • 纳入标准为报告100例及以上成人(年龄≥18岁)RA患者NAFLD患病率,NAFLD诊断基于影像学或组织学评估。
  • 最终纳入来自4大洲的9项合格研究,共2178例RA患者(78.8%为女性)。
  • 采用合并患病率、比值比和95%CI呈现结果,采用I²统计量衡量研究间异质性。

主要发现

  • RA患者NAFLD合并患病率为35.3%(95%CI 19.9-50.6;I²=98.6%;P<.001)。
  • 除1项研究采用瞬时弹性成像外,所有研究均采用超声诊断NAFLD。
  • 男性RA患者NAFLD合并患病率为35.2%(95%CI 24.0-46.5),女性为22.2%(95%CI 17.9-26.58),男性显著高于女性(交互作用P=.048)。
  • 体重指数每增加1单位与RA患者NAFLD风险直接相关,调整比值比为1.24(95%CI 1.17-1.31;I²=0.0%;P=.518)。

临床怎么用

  • 作者认为,临床医生应主动对RA患者进行NAFLD筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Previous studies have shown a potential association between nonalcoholic fatty liver disease (NAFLD) and some immune-mediated inflammatory diseases, such as rheumatoid arthritis (RA), but this association has not been analyzed systematically. Therefore, we aimed to perform a systematic review and meta-analysis to ascertain a pooled prevalence estimate of NAFLD among patients with RA to fill this gap in knowledge. METHODS: We conducted a literature search in PubMed, Embase, Web of Science, Scopus, and ProQuest, for observational studies published from inception to August 31, 2022, which reported prevalence of NAFLD in 100 or more adult (age, ≥18 y) patients with RA. To be included, NAFLD diagnosis was based on either imaging or histologic assessment. The results were presented as pooled prevalence, odds ratio, and 95% CI. The I2 statistic was used to measure the heterogeneity between studies. RESULTS: This systematic review included 9 eligible studies derived from 4 continents comprising 2178 patients (78.8% women) with RA. The pooled prevalence of NAFLD was 35.3% (95% CI, 19.9-50.6; I2 = 98.6%; P < .001) in patients with RA. All studies used ultrasound for the diagnosis of NAFLD, except for 1 study that used transient elastography. The pooled prevalence of NAFLD in men with RA was significantly higher than in women with RA (35.2%; 95% CI, 24.0-46.5 compared with 22.2%; 95% CI, 17.9-26.58; P for interaction = .048). Each 1-unit increase in body mass index was associated directly with a 24% increased risk of NAFLD in RA patients (adjusted odds ratio, 1.24; 95% CI, 1.17-1.31; I2 = 0.0%; P = .518). CONCLUSIONS: Based on this meta-analysis, 1 in 3 patients with RA had NAFLD, which appears comparable with its overall prevalence among the general population. Clinicians should actively screen for NAFLD in patients with RA.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Zamani M, Alizadeh-Tabari S, Chitkara P, et al. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2023. PMID: 36871771. doi:10.1016/j.cgh.2023.02.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。